Structured evidence table for Barley Beta Glucan Cholesterol Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Barley Beta Glucan Cholesterol Randomized Trial | Chronic diseases, characterized by their high prevalence and protracted course, represent a paramount challenge to global public health, necessitating effective, evidence-based preventive strategies. | 3 | Zhang X (2025) | From Broad-Spectrum Health to Targeted Prevention: A Review of Functional Foods in Chronic Disease Management. |
| Barley Beta Glucan Cholesterol Randomized Trial | This review bridges this critical gap by systematically evaluating the scientific evidence and application potential of functional foods, with a specific focus on key bioactive compounds-β-glucan, omega-3 polyunsaturated fatty acids (PUFAs), dietary fiber, and catechins. | 3 | Zhang X (2025) | From Broad-Spectrum Health to Targeted Prevention: A Review of Functional Foods in Chronic Disease Management. |
| Barley Beta Glucan Cholesterol Randomized Trial | Our unique contribution lies in integrating the ancient wisdom of food-medicine homology with modern multi-omics and evidence-based research, thereby proposing a refined nutritional intervention paradigm. | 3 | Zhang X (2025) | From Broad-Spectrum Health to Targeted Prevention: A Review of Functional Foods in Chronic Disease Management. |
| Barley Beta Glucan Cholesterol Randomized Trial | While functional foods are widely recognized for their potential, a comprehensive synthesis elucidating their multitargeted mechanisms within a "food-medicine homology" framework and a clear trajectory from broad-spectrum health promotion to targeted intervention remains lacking. | 3 | Zhang X (2025) | From Broad-Spectrum Health to Targeted Prevention: A Review of Functional Foods in Chronic Disease Management. |
| Barley Beta Glucan Cholesterol Randomized Trial | Functional prediction analysis specifically linked this microbial shift to the modulation of Akkermansia -associated metabolic pathways, which subsequently facilitated the activation of host metabolic networks to combat lipid deposition and systemic metabolic stress. | 4 | Guo Z (2026) | Combined Oat β-Glucan and Soy Protein Isolate Reprogram Gut Microbiota and Improve Metabolic Dysfunction in Diet-Induced Obesity. |
| Barley Beta Glucan Cholesterol Randomized Trial | Background/objectives Although plant-derived dietary fiber and protein are favorable factors for improving host metabolic disorders, it remains unclear whether these two macronutrients exhibit synergistic health benefits. | 4 | Guo Z (2026) | Combined Oat β-Glucan and Soy Protein Isolate Reprogram Gut Microbiota and Improve Metabolic Dysfunction in Diet-Induced Obesity. |
| Barley Beta Glucan Cholesterol Randomized Trial | Methods To address this gap, utilizing oat dietary fiber (GLU) and soybean protein (SBP) as representative bioactive models, we investigated the effects of 5% GLU, 20% SBP, and their combined supplementation on high-fat diet (HFD)-induced metabolic dysregulation in C57BL/6J mice. | 4 | Guo Z (2026) | Combined Oat β-Glucan and Soy Protein Isolate Reprogram Gut Microbiota and Improve Metabolic Dysfunction in Diet-Induced Obesity. |
Source documents